Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.23% | -21.43% | 0.09% | -121.67% | -0.20% |
| Total Depreciation and Amortization | 0.25% | 208.46% | 0.00% | 79.19% | 0.23% |
| Total Amortization of Deferred Charges | -- | -- | -0.07% | -- | -- |
| Total Other Non-Cash Items | 0.24% | 142.61% | 0.08% | -1,280.43% | -0.13% |
| Change in Net Operating Assets | -0.24% | -205.73% | -0.09% | 404.22% | 0.19% |
| Cash from Operations | -0.24% | -38.04% | 0.08% | -1,521.25% | 0.00% |
| Capital Expenditure | -0.41% | -112.28% | 0.87% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -0.09% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -3.70% | 0.00% | -8.16% | 0.23% |
| Cash from Investing | 0.00% | -94.33% | -0.08% | 487.98% | 0.23% |
| Total Debt Issued | 0.00% | 355.22% | 0.00% | 21.70% | 0.00% |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 13.68% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -43.93% | 0.00% | -1,493.33% | 0.00% |
| Cash from Financing | 0.23% | 3,925.52% | -0.35% | 21.10% | 0.00% |
| Foreign Exchange rate Adjustments | -0.23% | -89.90% | 0.09% | -147.26% | -0.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.24% | 293.83% | 0.09% | -11,173.68% | 0.00% |